Semaglutide improves health‐related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (
SUSTAIN
6)
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
Keyword(s):
2016 ◽
Vol 37
(2)
◽
pp. 183-189
Keyword(s):
Keyword(s):